Content on Cancer.Net is approved by the Cancer.Net Editorial Board, composed of more than 150 medical, surgical, radiation, and pediatric oncologists, oncology nurses, physician assistants, social workers, and patient advocates.
The Cancer.Net Editors Meeting was held virtually on October 19, 2021. Editor in Chief Jyoti D. Patel, MD, FASCO, and the site’s Associate Editors reviewed additions and updates to Cancer.Net over the past year, set the 2022 goals for ASCO’s patient education program, and provided expert guidance to ensure that Cancer.Net’s content is comprehensive, credible, current, and accessible for people with cancer.
From top left is Jyoti Patel, MD, FASCO (Editor in Chief), Charu Aggarwal, MD, MPH (Lung Cancer), Nina Shah, MD (Myeloma), and Merry Jennifer Markham, MD, FACP, FASCO (Gynecologic Cancers). Second row, from left is Christopher Flowers, MD, (Lymphoma), Karen Winkfield, MD, PhD (Health Equity and Radiation Oncology), Cristina Rodriguez, MD (Head and Neck Cancers), and Glen Lesser, MD, FACP (Central Nervous System Tumors). Third row, from left is Daniel Mulrooney, MD, MS (Pediatric Cancers), Sumanta Pal, MD, FASCO (Genitourinary (GU) Cancers), Richard T. Lee, MD (Palliative Care), and Fay Hlubocky, PhD, MA (Psychosocial Oncology). Fourth row is Jeffrey Meyerhardt, MD, MPH, FASCO (Gastrointestinal (GI) Cancers).
Not Pictured: William Dale, MD, PhD (Geriatric Oncology), Norah Lynn Henry, MD, PhD, FASCO (Breast Cancer), Vicki Keedy, MD (Sarcoma), and Ryan Sullivan, MD (Melanoma and Skin Cancer).
View more information about Cancer.Net’s Associate Editors, who lead the Cancer.Net Editorial Board.
View more information about Cancer.Net’s Specialty Editors, who provide topic-specific expertise as part of the Cancer.Net Editorial Board.
View a listing of Cancer.Net’s full advisory panel, which reviews content as part of the Cancer.Net Editorial Board.